US10509016B2ActiveUtilityA1
Methods for detecting lacosamide by mass spectrometry
Assignee: QUEST DIAGNOSTICS INVEST INCPriority: Dec 28, 2011Filed: Oct 18, 2017Granted: Dec 17, 2019
Est. expiryDec 28, 2031(~5.4 yrs left)· nominal 20-yr term from priority
H01J 49/004H01J 49/26Y10T436/24G01N 33/9473G01N 30/7266G01N 33/48Y10T436/25375H01J 49/0036G01N 33/487G01N 2560/00G01N 33/6848G01N 30/72G01N 33/6812H01J 49/00
87
PatentIndex Score
3
Cited by
44
References
16
Claims
Abstract
Provided are methods for determining the amount of lacosamide in a sample using mass spectrometry. The methods generally involve ionizing lacosamide in a sample and detecting and quantifying the amount of the ion to determine the amount of lacosamide in the sample.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1. A method for determining the amount of lacosamide in a sample, said method comprising:
a. subjecting the sample to protein precipitation;
b. purifying lacosamide from said sample by high performance liquid chromatography (HPLC);
c. ionizing lacosamide and an internal standard by electrospray ionization (ESI) to produce at least one lacosamide ion and at least one internal standard ion detectable by mass spectrometry, wherein the ions are fragmented with a collision energy of 35V;
d. determining an amount of said at least one lacosamide ion and an amount of said at least one internal standard ion by mass spectrometry; and
e. comparing the amount of said at least one lacosamide ion and the amount of said at least one internal standard ion to determine the amount of lacosamide in the sample.
2. The method of claim 1 , wherein said mass spectrometry is tandem mass spectrometry.
3. The method of claim 1 , wherein said sample is a body fluid.
4. The method of claim 1 , wherein said sample is plasma or serum.
5. The method of claim 1 , wherein said ionizing comprises generating a lacosamide precursor ion with a mass/charge ratio of 251.0±0.5, and generating one or more lacosamide fragment ions selected from the group consisting of ions with a mass/charge ratio of 91.0±0.5 and 108.0±0.5.
6. The method of claim 1 , wherein said internal standard is lacosamide-D3.
7. The method of claim 1 , wherein said ionizing comprises generating an internal standard precursor ion with a mass/charge ratio of 254.0±0.5, and generating an internal standard fragment ion with a mass/charge ratio of 91.0±0.5.
8. The method of claim 1 , wherein said ionizing is conducted in positive ion mode.
9. A method for determining the amount of lacosamide in a sample, said method comprising:
(i) subjecting the sample to protein precipitation;
(ii) purifying lacosamide from said sample by high performance liquid chromatography (HPLC);
(iii) ionizing lacosamide and an internal standard by electrospray ionization (ESI) to produce at least one lacosamide ion and at least one internal standard ion detectable by mass spectrometry, wherein the ions are fragmented with a collision energy of 35V;
(iv) determining an amount of said at least one lacosamide ion and an amount of said at least one internal standard ion by mass spectrometry; and
(v) comparing the amount of said ions of (iv) determined by mass spectrometry to determine the amount of lacosamide in the sample.
10. The method of claim 9 , wherein said mass spectrometry is tandem mass spectrometry.
11. The method of claim 9 , wherein said sample is a body fluid.
12. The method of claim 9 , wherein said sample is plasma or serum.
13. The method of claim 9 , wherein said ionizing comprises generating a lacosamide precursor ion with a mass/charge ratio of 251.0±0.5, and generating one or more lacosamide fragment ions selected from the group consisting of ions with a mass/charge ratio of 91.0±0.5 and 108.0±0.5.
14. The method of claim 9 , wherein said internal standard is lacosamide-D3.
15. The method of claim 9 , wherein said ionizing comprises generating an internal standard precursor ion with a mass/charge ratio of 254.0±0.5, and generating an internal standard fragment ion with a mass/charge ratio of 91.0±0.5.
16. The method of claim 9 , wherein said ionizing is conducted in positive ion mode.Join the waitlist — get patent alerts
Track US10509016B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.